Sponsor:
IRIS Research and Development, LLC
Code:
NCT06581562
Conditions
Rheumatoid Arthritis
Pemphigus Vulgaris
Granulomatosis With Polyangiitis
Systemic Lupus Erythematosus
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
AB-101
Rituximab
Cyclophosphamide
Fludarabine
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations